Alexander Cumbo
CIK 1685994 · President and CEO · last filed 2026-06-08
Alexander Cumbo is a President and CEO who has filed 38 SEC Form 4 insider transactions across 6 companies since 2017. The most recent filing, for ELYM, was dated Jun 8, 2026. Across all open-market trades the lifetime net is −$13.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.86M
6
38
-$13.38M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Climb Bio, Inc. (ELYM) Delisted | Director | — | $5.11 | — | $0 | 3 | 2026-06-08 |
| SLDB | President and CEO | 235,405 | $7.14 | $1.68M | -$1.12M | 12 | 2026-04-21 |
| Verve Therapeutics, Inc. (VERV) Delisted | Director | — | $11.13 | — | $0 | 5 | 2025-07-28 |
| VOR | Director | — | $14.36 | — | $0 | 1 | 2025-07-18 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | Director | — | — | — | $0 | 3 | 2020-04-03 |
| SRPT | EVP, Chief Commercial Officer | 12,008 | $15.31 | $183.8K | -$12.25M | 14 | 2020-02-28 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | Climb Bio, Inc. (ELYM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2026-04-21 | SLDB | Grant (A) | — | $0 | EDGAR |
| 2026-02-18 | SLDB | Mixed | +13,387 | -$96.9K | EDGAR |
| 2026-02-06 | SLDB | Sell (S) | −48,913 | -$315.1K | EDGAR |
| 2026-02-02 | SLDB | Mixed | +189,543 | -$516.6K | EDGAR |
| 2025-12-04 | SLDB | Mixed | +17,804 | -$55.2K | EDGAR |
| 2025-08-18 | SLDB | Grant (A) | — | $0 | EDGAR |
| 2025-07-28 | Verve Therapeutics, Inc. (VERV) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-07-18 | VOR | Grant (A) | — | $0 | EDGAR |
| 2025-06-06 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |